4-{[butyl(methyl)amino]sulfonyl}benzoic acid, 95.0%, 1g

4-(Methylsulfonyl)-2-morpholinobenzoic acid, 95.0%, 5g

5-Amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)pyrazole, 95.0%, 1g

Di-n-octyl sulfoxide, 98%, 1g

(R,R)-6-Benzyl-octahydro-pyrrolo[3,4-b]pyridine dihydrochloride, 97.0%, 250mg

(5S)-5,6-Dihydro-5-(1-methylethyl)-2-(2,4,6-trimethylphenyl)-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, >97.0%, 250mg

1-Ethylsulfonyl-piperazine, 99.0%, 5g

Ethyl 4-iodo-3-methylbenzoate, 98.0%, 1g

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride, 98.0%, 250mg

3-[3-(Difluoromethoxy)phenyl]propionic acid, 97%, 5g

6-CHLORO-1,2,3,4-TETRAHYDRONAPHTHALENE, 95.0%, 100mg

6-AMINO-3-BOC-3-AZABICYCLO[3.1.0]HEXANE, 95.0%, 250mg

Adénosine, min 99 %, pa, 25 g, emballage plastique.